Vachon Mark

Avg. Two Year Performance

No purchase track record
59% Avg. Sale Return
26% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return15%(5%)9%29%59%
Sale Success Rate3 of 42 of 43 of 43 of 44 of 4

Bluebird Bio, Inc.

Drugs » Biotechnology

Director:

Holdings: 25.04K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--